Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening, Enhancement of Access to Care and Prioritization of Treatment for Chronic Hepatitis C Infection in High-risk Populations in Hong Kong

NCT03993925 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03993925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03993925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening, Enhancement of Access to Care and Prioritization of Treatment for Chronic Hepatitis C Infection in High-risk Populations in Hong Kong
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Active, not recruiting
Start date
September 20, 2019
Completion date
December 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, intravenous drug usage